Page 2 - Amrx News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Amrx. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Amrx Today - Breaking & Trending Today
Connor Clark & Lunn Investment Management Ltd. raised its position in Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX – Free Report) by 27.8% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 492,304 shares of the company’s stock after buying an additional 107,090 shares […] ....
Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX – Get Free Report) fell 6.4% during trading on Tuesday . The company traded as low as $5.45 and last traded at $5.45. 697,403 shares traded hands during mid-day trading, a decline of 45% from the average session volume of 1,278,588 shares. The stock had previously closed at $5.82. Wall Street […] ....
Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX – Get Free Report)’s share price traded down 6.4% during trading on Tuesday . The stock traded as low as $5.45 and last traded at $5.45. 697,403 shares traded hands during trading, a decline of 45% from the average session volume of 1,278,588 shares. The stock had previously closed at $5.82. […] ....
Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX – Get Free Report) has been given an average recommendation of “Moderate Buy” by the five research firms that are presently covering the firm, Marketbeat reports. One investment analyst has rated the stock with a hold rating and four have issued a buy rating on the company. The average twelve-month target […] ....
Tejara Capital Ltd purchased a new stake in shares of Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX – Free Report) in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 96,672 shares of the company’s stock, valued at approximately $408,000. A number of […] ....